Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

In Vivo Effectiveness of Orlistat in the Suppression of Human Colorectal Cancer Cell Proliferation.

Czumaj A, Zabielska J, Pakiet A, Mika A, Rostkowska O, Makarewicz W, Kobiela J, Sledzinski T, Stelmanska E.

Anticancer Res. 2019 Jul;39(7):3815-3822. doi: 10.21873/anticanres.13531.

PMID:
31262909
2.

Acyl-Coenzyme A: Cholesterol Acyltransferase Inhibition in Cancer Treatment.

Zabielska J, Sledzinski T, Stelmanska E.

Anticancer Res. 2019 Jul;39(7):3385-3394. doi: 10.21873/anticanres.13482. Review.

PMID:
31262860
3.

Inhibitors of Protein Tyrosine Phosphatase PTP1B With Anticancer Potential.

Kostrzewa T, Styszko J, Gorska-Ponikowska M, Sledzinski T, Kuban-Jankowska A.

Anticancer Res. 2019 Jul;39(7):3379-3384. doi: 10.21873/anticanres.13481. Review.

PMID:
31262859
4.

Exercise and Conjugated Linoleic Acid Supplementation Induce Changes in the Composition of Liver Fatty Acids.

Mika A, Czumaj A, Stepnowski P, Macaluso F, Spinoso G, Barone R, Di Felice V, Sledzinski T.

Front Physiol. 2019 May 15;10:602. doi: 10.3389/fphys.2019.00602. eCollection 2019.

5.

Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism.

Czumaj A, Śledziński T, Carrero JJ, Stepnowski P, Sikorska-Wisniewska M, Chmielewski M, Mika A.

Int J Mol Sci. 2019 May 18;20(10). pii: E2470. doi: 10.3390/ijms20102470.

6.

Modern Methods of Sample Preparation for the Analysis of Oxylipins in Biological Samples.

Liakh I, Pakiet A, Sledzinski T, Mika A.

Molecules. 2019 Apr 25;24(8). pii: E1639. doi: 10.3390/molecules24081639. Review.

7.

Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.

Kordalewska M, Macioszek S, Wawrzyniak R, Sikorska-Wiśniewska M, Śledziński T, Chmielewski M, Mika A, Markuszewski MJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 1;1117:49-57. doi: 10.1016/j.jchromb.2019.04.003. Epub 2019 Apr 3.

PMID:
30999273
8.

Effect of Exercise on Fatty Acid Metabolism and Adipokine Secretion in Adipose Tissue.

Mika A, Macaluso F, Barone R, Di Felice V, Sledzinski T.

Front Physiol. 2019 Jan 28;10:26. doi: 10.3389/fphys.2019.00026. eCollection 2019. Review.

9.

Changes in lipids composition and metabolism in colorectal cancer: a review.

Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A.

Lipids Health Dis. 2019 Jan 26;18(1):29. doi: 10.1186/s12944-019-0977-8. Review.

10.

Up-regulation of PCSK9 gene expression and diminished level of LDL-receptor in rat liver as a potential cause of post-lipectomy hypercholesterolemia.

Dettlaff-Pokora A, Sucajtys-Szulc E, Sledzinski T.

Mol Cell Biochem. 2019 May;455(1-2):207-217. doi: 10.1007/s11010-018-3484-8. Epub 2018 Nov 27.

11.

Potential contribution of monounsaturated fatty acids to cardiovascular risk in chronic kidney disease.

Mika A, Sikorska-Wiśniewska M, Małgorzewicz S, Stepnowski P, Dębska-Ślizień A, Śledziński T, Chmielewski M.

Pol Arch Intern Med. 2018 Dec 21;128(12):755-763. doi: 10.20452/pamw.4376. Epub 2018 Nov 20.

12.

Decreased serum level of nitric oxide in children with excessive body weight.

Czumaj A, Śledzińska M, Brzeziński M, Szlagatys-Sidorkiewicz A, Słomińska E, Śledziński T.

Adv Clin Exp Med. 2019 Apr;28(4):439-446. doi: 10.17219/acem/77982.

13.

Evidence That the Length of Bile Loop Determines Serum Bile Acid Concentration and Glycemic Control After Bariatric Surgery.

Mika A, Kaska L, Proczko-Stepaniak M, Chomiczewska A, Swierczynski J, Smolenski RT, Sledzinski T.

Obes Surg. 2018 Nov;28(11):3405-3414. doi: 10.1007/s11695-018-3314-9.

PMID:
29790128
14.

Cyclopropaneoctanoic Acid 2-Hexyl Upregulates the Expression of Genes Responsible for Lipid Synthesis and Release in Human Hepatic HepG2 Cells.

Czumaj A, Mika A, Chmielewski M, Sledzinski T.

Lipids. 2018 Mar;53(3):345-351. doi: 10.1002/lipd.12034.

PMID:
29701265
15.

Dominant ELOVL1 mutation causes neurological disorder with ichthyotic keratoderma, spasticity, hypomyelination and dysmorphic features.

Kutkowska-Kaźmierczak A, Rydzanicz M, Chlebowski A, Kłosowska-Kosicka K, Mika A, Gruchota J, Jurkiewicz E, Kowalewski C, Pollak A, Stradomska TJ, Kmieć T, Jakubowski R, Gasperowicz P, Walczak A, Śladowski D, Jankowska-Steifer E, Korniszewski L, Kosińska J, Obersztyn E, Nowak W, Śledziński T, Dziembowski A, Płoski R.

J Med Genet. 2018 Jun;55(6):408-414. doi: 10.1136/jmedgenet-2017-105172. Epub 2018 Mar 1.

PMID:
29496980
16.

Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure.

Sucajtys-Szulc E, Debska-Slizien A, Rutkowski B, Milczarek R, Pelikant-Malecka I, Sledzinski T, Swierczynski J, Szolkiewicz M.

Mol Cell Biochem. 2018 Sep;446(1-2):11-23. doi: 10.1007/s11010-018-3268-1. Epub 2018 Jan 12.

17.

Potential Application of 1H NMR for Routine Serum Lipidome Analysis -Evaluation of Effects of Bariatric Surgery.

Mika A, Kaczynski Z, Stepnowski P, Kaczor M, Proczko-Stepaniak M, Kaska L, Sledzinski T.

Sci Rep. 2017 Nov 14;7(1):15530. doi: 10.1038/s41598-017-15346-0.

18.

Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.

Mika A, Wojtowicz W, Ząbek A, Młynarz P, Chmielewski M, Sledzinski T, Stepnowski P.

J Pharm Biomed Anal. 2018 Feb 5;149:1-8. doi: 10.1016/j.jpba.2017.10.037. Epub 2017 Oct 31.

PMID:
29100025
19.

Orlistat Reduces Proliferation and Enhances Apoptosis in Human Pancreatic Cancer Cells (PANC-1).

Sokolowska E, Presler M, Goyke E, Milczarek R, Swierczynski J, Sledzinski T.

Anticancer Res. 2017 Nov;37(11):6321-6327.

PMID:
29061815
20.

Current Progress of Lipid Analysis in Metabolic Diseases by Mass Spectrometry Methods.

Mika A, Sledzinski T, Stepnowski P.

Curr Med Chem. 2019;26(1):60-103. doi: 10.2174/0929867324666171003121127. Review.

PMID:
28971757

Supplemental Content

Loading ...
Support Center